Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Clinics in Laboratory MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
IMS data US national prescription audit; MAT (moving annual total) 2011–2012. Avaiable at: http://www.imshealth.com/ims/Global/Content/Insights/IMS%20Institute%20for%20Healthcare%20Informatics/IHII_Medicines_in_U.S_Report_2011.pdf.
- Rates of hemorrhage during warfarin therapy for atrial fibrillation.CMAJ. 2013; 185: E121-E127
- Emergency hospitalizations for adverse drug events in older Americans.N Engl J Med. 2011; 365: 2002-2012
- National estimates of emergency department visits for hemorrhage-related adverse events from clopidogrel plus aspirin and from warfarin.Arch Intern Med. 2010; 170: 1926-1933
- Bleeding complications with warfarin use: a prevalent adverse effect resulting in regulatory action.Arch Intern Med. 2007; 167: 1414-1419
- Timing of fresh frozen plasma administration and rapid correction of coagulopathy in warfarin-related intracerebral hemorrhage.Stroke. 2006; 37: 151-155
- Treatment of warfarin-associated intracerebral hemorrhage: literature review and expert opinion.Mayo Clin Proc. 2007; 82: 82-92
- American Heart Association/American College of Cardiology Foundation guide to warfarin therapy.Circulation. 2003; 107: 1692-1711
- Guidelines on oral anticoagulation with warfarin—fourth edition.Br J Haematol. 2011; 154: 311-324
- Evidence-based management of anticoagulant therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines.Chest. 2012; 141: e152S-e184S
- French clinical practice guidelines on the management of patients on vitamin K antagonists in at-risk situations (overdose, risk of bleeding, and active bleeding).Thromb Res. 2010; 126: e167-e174
- Perioperative hemostatic management of patients treated with vitamin K antagonists.Anesthesiology. 2008; 109: 918-926
- Oral anticoagulant therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines.Chest. 2012; 141: e44S-e88S
- Transfusion-associated circulatory overload after plasma transfusion.Transfusion. 2012; 52: 160-165
- Fluid overload is associated with increases in length of stay and hospital costs: pooled analysis of data from more than 600 US hospitals.Clinicoecon Outcomes Res. 2013; 5: 289-296
- Emergency reversal of anticoagulation after intracerebral hemorrhage.Stroke. 1992; 23: 972-977
- Emergency oral anticoagulant reversal: the relative efficacy of infusions of fresh frozen plasma and clotting factor concentrate on correction of the coagulopathy.Thromb Haemost. 1997; 77: 477-480
- Warfarin reversal.J Clin Pathol. 2004; 57: 1132-1139
- 4 Plasma for therapeutic use.Transfus Med Hemother. 2009; 36: 388-397
- Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology.Eur J Anaesthesiol. 2013; 30: 270-382
- Management of bleeding and coagulopathy following major trauma: an updated European guideline.Crit Care. 2013; 17: R76
- Prothrombin complex concentrate (Beriplex P/N) for emergency anticoagulation reversal: a prospective multinational clinical trial.J Thromb Haemost. 2008; 6: 622-631
- A protocol for the rapid normalization of INR in trauma patients with intracranial hemorrhage on prescribed warfarin therapy.Am Surg. 2008; 74: 858-861
- An observational, prospective, two-cohort comparison of a fixed versus variable dosing strategy of prothrombin complex concentrate to counteract vitamin K antagonists in 240 bleeding emergencies.Haematologica. 2012; 97: 1501-1506
- Prothrombin complex concentrate (Beriplex P/N) in severe bleeding: experience in a large tertiary hospital.Crit Care. 2008; 12: R105
- Prothrombin complex concentrate (Beriplex P/N).Drugs. 2009; 69: 1977-1984
- Efficacy and safety of a 4-Factor prothrombin complex concentrate in patients on vitamin K antagonists presenting with major bleeding: a randomized, plasma-controlled, phase IIIb study.Circulation. 2013; 128: 1234-1243
- Outcomes of urgent warfarin reversal with frozen plasma versus prothrombin complex concentrate in the emergency department.Circulation. 2013; 128: 360-364
Kcentra US prescribing information. 2013. Available at: http://www.kcentra.com/docs/Kcentra_Prescribing_Information.pdf.
- Safety of prothrombin complex concentrates for rapid anticoagulation reversal of vitamin K antagonists. A meta-analysis.Thromb Haemost. 2011; 106: 429-438
- Impact of infusion speed on the safety and effectiveness of prothrombin complex concentrate: a prospective clinical trial of emergency anticoagulation reversal.Ann Hematol. 2010; 89: 309-316
- Suboptimal effect of a three-factor prothrombin complex concentrate (Profilnine-SD) in correcting supratherapeutic international normalized ratio due to warfarin overdose.Transfusion. 2009; 49: 1171-1177
- Modeling the cost-effectiveness of prothrombin complex concentrate compared with fresh frozen plasma in emergency warfarin reversal in the United Kingdom.Clin Ther. 2010; 32: 2478-2493
Article info
Publication history
Published online: July 22, 2014
Footnotes
Conflict of Interest Statement: Dr R. Sarode has a working relationship (consulting and advisory) with CSL Behring, Marburg, Germany.
Identification
Copyright
© 2014 Elsevier Inc. Published by Elsevier Inc. All rights reserved.
